These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9622225)

  • 1. Effect of implantation of human apoAI gene on apoprotein composition and vasoactive properties of high-density lipoproteins in rats at different ages.
    Frolkis VV; Kulchitsky OK; Kordjum VA; Novikova SN; Sikalo NV; Potapenko RI; Irodov DM; Bogatskaya LN; Burchinskaya MK; Mozzhukhina TG
    Mech Ageing Dev; 1998 Apr; 101(3):213-9. PubMed ID: 9622225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of human apolipoprotein A-I gene on vasoactive properties of high density lipoproteins in rats of different age].
    Frol'kis VV; Kordium VA; Kul'chitskiĭ OK; Novikova SN; Sykalo NV; Bogatskaia LN; Potapenko RI; Burchinskaia MK; Mozzhukhina TG; Irodov DM
    Biull Eksp Biol Med; 1998 May; 125(5):506-8. PubMed ID: 9644544
    [No Abstract]   [Full Text] [Related]  

  • 3. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells.
    Francis GA; Tsujita M; Terry TL
    Biochemistry; 1999 Dec; 38(49):16315-22. PubMed ID: 10587456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
    Holvoet P; Danloy S; Collen D
    Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High density lipoproteins in the blood of rats of varying age].
    Frol'kis VV; Bogatskaia LN; Novikova SN; Potanpenko RI; Mozzhukhina TG; Sabko VE
    Ukr Biokhim Zh (1978); 1992; 64(4):56-61. PubMed ID: 1448875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrium of apoproteins between high density lipoprotein and the aqueous phase: modelling of in vivo metabolism.
    Ponsin G; Pownall HJ
    J Theor Biol; 1985 Jan; 112(1):183-92. PubMed ID: 3974262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism.
    Srivastava RA
    Biochem Mol Biol Int; 1994 Sep; 34(2):393-402. PubMed ID: 7849650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
    Srivastava RA; Krul ES; Lin RC; Schonfeld G
    Mol Cell Biochem; 1997 Aug; 173(1-2):161-8. PubMed ID: 9278267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reciprocal exchange of apoproteins and nonpolar lipids between human high density lipoproteins and an artificial triglyceride-phospholipid emulsion (Intralipid).
    Weinberg RB; Scanu AM
    Atherosclerosis; 1982 Aug; 44(2):141-52. PubMed ID: 7138616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
    Rubin EM; Ishida BY; Clift SM; Krauss RM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origin and fate of HDL.
    Roheim PS
    Adv Exp Med Biol; 1977; 82():421-6. PubMed ID: 200102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins.
    Nion S; Demoor L; Boutillon C; Luchoomun J; Vanloo B; Fievet C; Castro G; Rosseneu M; Fruchart JC; Tartar A; Clavey V
    Atherosclerosis; 1998 Dec; 141(2):227-35. PubMed ID: 9862171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
    Kashyap SR; Osme A; Ilchenko S; Golizeh M; Lee K; Wang S; Bena J; Previs SF; Smith JD; Kasumov T
    J Clin Endocrinol Metab; 2018 Feb; 103(2):388-396. PubMed ID: 29077935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of apolipoprotein AI from apoprotein-lipid complexes and from high-density lipoproteins. A fluorescence study.
    Rosseneu M; Van Tornout P; Lievens MJ; Schmitz G; Assmann G
    Eur J Biochem; 1982 Nov; 128(2-3):455-60. PubMed ID: 6818027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.